INTRODUCTION
HIV-infected individuals are at an increased risk of developing dyslipidemia and insulin resistance, which seems to be due, in part, to adverse changes in adipocyte metabolic fitness. [1] [2] [3] [4] [5] [6] [7] Exposure to HIV viral proteins and antiretroviral therapy (ART) agents depletes adipocyte mitochondrial DNA and electron transport chain proteins, which is accompanied by impaired fatty acid metabolism, altered adipokine secretion, and reduced insulin sensitivity. [8] [9] [10] [11] [12] [13] [14] [15] Adipose tissue from HIV-infected persons also has lower expression of key adipocyte regulatory proteins involved in maturation and the control of lipid storage and release. [16] [17] [18] [19] [20] [21] [22] [23] The stromal vascular fraction of adipose tissue contains a diverse mix of immune cells forming a complex paracrine signaling milieu, which modulates local inflammation and adipocyte function. Studies in animal models and HIVnegative persons demonstrate the central role of T cells in regulating local inflammation, adipocyte gene expression, energy uptake, and metabolic homeostasis in subcutaneous and visceral fat. [24] [25] [26] [27] [28] [29] [30] [31] CD8 + T-cell infiltration into adipose tissue is an early and necessary step preceding the recruitment of M1 phenotype [tumor necrosis factor-a, interleukin (IL)-6-, IL-12-, and IL-23-producing] macrophages, which act through adipocyte surface receptors and other mechanisms to inhibit insulin signaling by reducing expression of insulin receptor substrate-1, phosphoinositide 3-kinase p85a, and glucose transporter type 4. 24, 28, 30, [32] [33] [34] [35] [36] Furthermore, spectrotype analyses of adipose tissue CD8 + T cells in the setting of obesity have described a conserved repertoire of T-cell receptor (TCR) Va and Vb chain families as compared to cells in lean tissue, suggesting that these CD8 + T cells may undergo oligoclonal expansion in adipose tissue. 24, 37 Alterations in adipose tissue T-cell distributions are also observed in the setting of HIV infection. Adipose tissue from HIV-infected persons has a lower percentage of CD4 + memory T cells and higher CD8 + memory T cells compared with HIV-negative persons. 36 Furthermore, both the CD4 + and CD8 + memory T cells predominantly express the CD69 activation marker, and the median copy number of latent HIV DNA in adipose tissue CD4 + T cells is similar to the median copy number in circulating CD4 + T cells. 35, 36 Coculture of preadipocytes with CD4 + T cells harboring latent HIV virus in vitro increases preadipocyte IL-6 expression nearly 3-fold, and this finding may reflect an in vivo process contributing to adipose tissue inflammation in HIV-infected persons. 36 Similar changes are observed in studies of simian immunodeficiency virus (SIV), where SIV infection is accompanied by a significantly higher proportion of activated CD4 + and CD8 + cells in both subcutaneous and visceral adipose tissue compared with uninfected animals, and the mean level of SIV RNA in adipose tissue is similar to CD4 + T cells in circulation and in mesenteric lymph nodes. 35 In this study, we sought to extend our understanding of adipose tissue immunology in HIV-infected persons and assess whether adipose tissue is enriched for CD4 + and CD8 + T cells expressing activation, exhaustion, late differentiation/senescence, and memory surface markers compared with blood. Furthermore, we compare the relative CD8 + Tcell oligoclonality and TCR Vb gene family usage, and the frequency of latently HIV-infected CD4 + T cells in adipose tissue compared with blood among HIV-infected adults on long-term ART with sustained viral suppression.
METHODS
Participants were recruited from an existing cohort enrolled to study the effects of HIV infection and obesity on metabolic disease, which has been previously described. 38, 39 All subjects had received efavirenz, tenofovir, and emtricitabine (EFV/TDF/FTC; combination pill Atripla) for a minimum of 4 years and had consistent HIV-1 RNA measurements ,50 copies/mL for at least the previous 3 years (single viral "blips" of ,1000 copies/mL followed by measurements ,50 copies/mL and no documentation of missed doses or poor adherence were allowed). Additional inclusion criteria were a blood CD4 + T-cell count .350 cells/ mL at the time of enrollment, no use of any antidiabetic or statin medication, no self-reported heavy alcohol (defined as .11 drinks/wk) or cocaine/amphetamine use, no active infectious conditions aside from HIV, and no previously diagnosed diabetes, cardiovascular, or rheumatologic disease.
All visits occurred in the Vanderbilt Clinical Research Center between 8 and 11 AM. Subjects fasted for a minimum of 8 hours, and blood was collected for mononuclear cell separation before other procedures. Subcutaneous abdominal adipose tissue biopsies were collected approximately 3 cm to the right of the umbilicus after anesthetizing the skin with lidocaine and infiltrating 10 mL of sterile saline and lidocaine as tumescent fluid. We collected 3-5 g of adipose tissue using a 2.7-mm blunt, side-ported liposuction catheter (Tulip CellFriendly GEMS system Carraway Harvester, Tulip Medical Products, San Diego, CA) designed for the extraction of viable adipocytes and stromal vascular cells during cosmetic adipose tissue transfer procedures. 40 Tissue was recovered in droplets of generally less than 3 mm diameter, limiting the need to mechanically mince the sample, and repeatedly rinsed with saline to eliminate contamination by blood. The adipose tissue was placed in a gentleMACS Dissociator (Miltenyi Biotec, Bergisch Gladbach, Germany), followed by incubation with collagenase. Mononuclear cells were separated by Ficoll-Paque Plus density gradient and cryopreserved in fetal bovine serum with 10% dimethylsulfoxide.
Blood and adipose tissue mononuclear cell aliquots were thawed and stained for CD3, CD4, CD8, activation (CD38, HLA-DR, and CD69), exhaustion (PD1), late differentiation/senescence (CD57), and memory (CD45RO) surface markers. Cells were run on a Fortessa (Becton Dickson Biosciences, San Jose, CA) flow cytometer, and CD4 + and CD8 + T cells were separated by fluorescence-activated cell sorting (FACS) for subsequent assays. The percentage of each T-cell subset was assessed using FACSDiva software (Becton Dickson Biosciences).
We purified genomic DNA from sorted CD4 + and CD8 + T cells using the DNA IQ System (Promega, Madison, WI). DNA from adipose tissue and blood CD4 + T cells was used to compare the size of the latent HIV reservoir using the QX200 droplet digital PCR system and polymerase kit (BioRad Laboratories, Hercules, CA), with primers and probes specific for the HIV LTR and gag genes. Reactions were partitioned into oil droplets using an automated droplet generator. We quantified the positive droplets that contained amplified HIV sequences (QuantaSoft software; Bio-Rad Laboratories); the number of HIV-1 gag or LTR copies was normalized with the RNaseP housekeeping gene, and then extrapolated to calculate the mean number of HIV copies per million CD4 + T cells.
DNA from adipose tissue and blood CD8 + T cells was used for bulk TCRb CDR3 region amplification and sequencing using the ImmunoSEQ assay (Adaptive Biotechnologies, Seattle, WA). 41, 42 In this method, bias-controlled V and J gene primers are used to amplify rearranged V(D)J segments for sequencing. Nonproductive sequences were identified by nontemplated insertions or deletions, which produced frameshifts or premature stop codons and were excluded from analysis. Extracted DNA from a minimum of 300,000 sorted CD8 + T cells was sequenced for all blood samples. Extracted DNA was sequenced from the 7 adipose tissue samples that yielded more than 1000 sorted CD8 + T cells (range 1480-24,890 cells); the remaining 3 samples yielded CD8 + T-cell counts below the recommended 1000 cell limit of the ImmunoSEQ assay. Two adipose tissue samples yielded less than 100 productive TCRb sequence reads and were excluded, yielding a final sample of 5 paired adipose and blood TCRb repertoires. The blood CD8 + TCRb repertoire from subject 4 had a lower clonality score (0.021) compared with other subjects (range 0.079-0.226). Therefore, a second DNA sample from subject 4 was sequenced, which confirmed both the clonality score and the identity and frequency of the most prevalent sequences.
All subjects provided written informed consent, and study procedures were in accordance with the human experimentation ethical standards of the Vanderbilt Institutional Review Board and with the Helsinki Declaration of 1975, as revised in 2000.
Statistical Analysis
We compared the percentage of CD4 + and CD8 + T cells expressing each surface marker in paired blood and adipose tissue samples using Wilcoxon signed-rank tests. Raw amino acid and nucleotide data were exported from the Adaptive Biosciences ImmunoSEQ analyzer, and the TCRb V and J sequences were aligned using the international ImMunoGeneTics (IMGT) information system. 43 We compared the CD8 + TCRb repertoire diversity in adipose tissue versus blood using the tcR R statistics package. 44 Proportional downsampling and bootstrapping were used to account for read-count distribution differences between tissue compartments and between patients. Frequencies of TCRb V and J gene usage, and V-J gene pairing, were analyzed using the opensource VDJtools software package (https://github.com/mikessh/ vdjtools). 45 Analysis of variance was used for comparisons between adipose and blood samples, and between subjects.
RESULTS
The demographic and clinical characteristics of the 10 subjects are shown in Table 1 . Six subjects were women, 7
were nonwhite, median age was 46 years [interquartile range (IQR) [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] , median blood CD4 + T-cell count was 819 cells/mL (IQR 697-1113), and median duration of ART was 9.6 years (IQR 6.8-14.3). All subjects were overweight or obese (body mass index . 25.0 kg/m 2 ), and the median body mass index was 32.8 kg/m 2 (IQR 28.5-36.5). None of the subjects were diabetic according to hemoglobin A1c criteria (ie, $6.5%); however, 5 subjects were prediabetic (hemoglobin A1c 5.7%-6.4%).
Adipose tissue contained a lower percentage of CD4 + T cells and a higher percentage of CD8 + cells, in comparison with blood (Table 2 ; P , 0.01 for both). The percentage of CD8 + T cells expressing the HLA-DR activation marker in adipose tissue was over 6-fold higher compared with those in blood (5.5% vs. 0.9%, P , 0.01). Similarly, the percentage of CD8 + T cells expressing CD57, a marker of late differentiation or replicative senescence, was significantly higher in adipose tissue than in blood (37.4% vs. 22.7%, P , 0.01). Adipose tissue was also enriched for CD4 + T cells expressing CD57 (5.7% vs. 2.2%, P , 0.01) and HLA-DR (3.5% vs. 1.0%, P , 0.01), although at lower absolute levels as compared to the CD8 + T cells. Adipose tissue CD4 + T-cell expression of the TCR-coupled CD69 activation marker was over 5-fold higher compared with blood, but among memory CD4 + CD45RO + T cells, the CD69 expression in adipose tissue was 20-fold higher (5.9% vs. 0.3%, P = 0.04).
Latent HIV DNA was detected in the 2 adipose tissue samples with more than 5000 sorted CD4 + T cells, but not in samples with fewer CD4 + cells; in both subjects, the copy number was higher in adipose tissue CD4 + cells compared with blood (3.50 vs. 3.14 and 3.46 vs. 3.22, log DNA copies/ million CD4 + cells).
Five adipose tissue samples yielded sufficient CD8 + TCRb sequences (range 319-4548 productive templates) for analysis. The 10 most prevalent TCRb clones comprised a larger percentage of total clones in adipose tissue compared with paired blood in all 5 subjects (25% vs. 16% of total repertoire, respectively; P = 0.04, Fig. 1 ), and the Shannon Entropy index, a measure of overall repertoire diversity, was lower in adipose tissue compared with blood (4.39 vs. 4.46, respectively; P = 0.05). Notably, we did not observe the same TCRb sequences, also referred to as public clonotypes (ie, specific rearrangements observed in multiple individuals), occurring at greater than 0.9% frequency in adipose tissue among any 2 study subjects. We graphed V and J gene pairing in adipose tissue versus blood using Circos plots (Fig.  2 ). These plots demonstrate visual differences in gene usage and V-J gene pairing between blood and adipose tissue, but these differences were not statistically significant between the 5 subjects (P = 0.12).
DISCUSSION
In this study, we found that the subcutaneous adipose tissue of overweight and obese patients with HIV on longterm ART is enriched for both activated and latedifferentiated CD4 + and CD8 + T cells compared with blood, and the overall population of CD8 + cells in adipose tissue demonstrates greater clonality and a higher fraction of the repertoire devoted to the most prevalent TCRb sequences. The increased proportion of antigen-stimulated activated, latedifferentiated, and memory CD8 + T cells in adipose tissue, as opposed to naive cells, would be expected to confer a more clonal TCRb repertoire. However, the finding that the most prevalent V and J gene pairings seem to differ between tissue compartments suggests that the adipose tissue TCRb repertoire does not simply represent a concentration of the most common blood sequences, as might be observed if activated and memory T cells collected in adipose tissue in a random manner. This is the first study, to our knowledge, to use TCR sequencing to compare clone repertoires in blood and adipose tissue compartments from HIV-infected persons. Although CD8 + TCRb clonality was greater in every adipose tissue sample compared with the matched blood, there was minimal shared sequence homology between subjects, indicating a lack of public clonotypes characteristic of conserved antigenic stimuli. This finding could indicate a "founder effect" in which certain adipose tissue CD8 + T cells undergo oligoclonal expansion in the presence of local stimuli, such as IL-2, and fail to egress and equilibrate with the blood. Alternately, this finding could also reflect a homing of specific CD8 + cells to adipose tissue and expansion in response to a unique antigen or neoantigen, as might result from oxidative damage or other protein modifications.
Although previous studies have shown higher CD4 + and CD8 + T-cell expression of HLA-DR in the adipose tissue of SIV-infected macaques compared with blood, we are not aware of previous studies in HIV-infected humans or animal models showing an enrichment of CD57 + T cells. Expression of CD57, a terminally sulfated glycan carbohydrate epitope, on T cells is considered a marker of late differentiation and reduced replicative capacity, or an inability to proliferate in response to antigen stimulation and increased susceptibility to activationinduced apoptosis. [46] [47] [48] A higher percentage of CD57 + T cells is implicated in several inflammatory diseases, [49] [50] [51] and CD57 expression on CD4 + and CD8 + T cells in the blood is higher in HIV-infected persons compared with HIV-negative. 48, 52, 53 We observed a far higher percentage of CD8 + T cells expressing CD57, (37.4%) compared with CD4 + T cells expressing CD57 (5.7%), in adipose tissue. CD8 + T cells expressing CD57 have higher interferon-g and tumor necrosis factor-a production after TCR stimulation compared with CD8 + CD57 2 T cells and demonstrate a distinct gene expression profile characterized by greater cytotoxic effector potential (eg, production of perforin, granzymes, and granulysin), greater adhesion molecule expression, and reduced chemokine receptor expression. 54, 55 Granulysin is one of the most overexpressed genes in CD8 + CD57 + compared with CD8 + CD57 2 T cells and a central component in the granules of cytotoxic T cells and NK cells, which serves as a potent immune cell chemoattractant and proinflammatory activator. [56] [57] [58] A central question for further research is whether the percentage of CD8 + CD57 + T cells in adipose tissue is higher in HIV-infected persons compared with HIV-negative, and whether these cells are expressing a cytokine profile that contributes to a local inflammatory environment and changes in adipocyte function.
Our study findings contribute to the limited literature on adipose tissue T cells in HIV-infected persons or SIV-infected macaques. 35, 36, 59, 60 A study combining subcutaneous and visceral adipose tissue from live donors and cadavers found a higher proportion of memory (CD45RO + ) CD8 + T cells and lower memory CD4 + T cells in the adipose tissue of HIVinfected subjects as compared to HIV-negative controls, and the memory cells predominantly expressed the CD69 activation marker, suggesting the possible presence of receptor stimulation in the local environment. 36 Two studies of cynomolgus macaques found that SIV infection was associated with a higher percentage of CD8 + T cells and lower CD4 + T cells in both the subcutaneous and visceral adipose tissue compared with uninfected animals. 35, 59 The percentage of activated (HLA-DR + ) CD4 + and CD8 + T cells and the density of activated macrophages were significantly higher in subcutaneous and visceral adipose tissue of SIV-infected animals compared with uninfected controls. 35 Adipocytes from SIV-infected macaques also have lower CCAAT enhancer-binding protein-a (C/EBPa; a master transcription factor controlling adipogenesis), C/EBPb, leptin, and glucose transporter type 4 expression compared with uninfected animals, but higher expressions of IL-2, IL-7, and CCL19, 3 cytokines that may contribute to the homing and survival of T cells in adipose tissue. 59 Irrespective of HIV infection, the presence of activated and memory CD4 + and CD8 + T cells in adipose tissue contributes to local inflammation and reduced adipocyte insulin sensitivity and energy storage. Infiltration of several T-cell subtypes, including CD4 + Th1-type cells, 26, 31, 37, 61 CD8 + cytotoxic T cells, 24, 37, 62 and natural killer T cells, 63, 64 promotes the recruitment of M1-phenotype macrophages and other innate immune cells. These cells secrete inflammatory cytokines and chemokines that inhibit adipocyte insulin signaling through changes in gene transcription and the phosphorylation of insulin receptor substrate-1. [28] [29] [30] Furthermore, in vitro studies have found that obese fat independently activates CD8 + T cells and induces proliferation, whereas lean fat has little effect. 24 Analyses of adipose tissue CD8 + T cells in the setting of obesity have also identified a predominance of memory cells and a relatively conserved repertoire of TCR Va and Vb chain families, indicating that these cells may undergo oligoclonal expansion. 24, 26, 37 Lastly, experimental models depleting CD8 + T cells in adipose tissue result in reduced macrophage density and improved insulin sensitivity, suggesting that immunotherapy could have a future application in the management of metabolic disease. 24, 26, 65, 66 Further studies are needed to understand the etiology of the oligoclonal expansion of CD8 + T cells in adipose tissue. As noted above, this could result from a TCR specificityindependent mechanism in which random activated and memory T cells enter the adipose tissue, adopt a tissue-resident phenotype inhibiting egress to the blood, and then expand in response to local IL-2 or other cytokines. It may also represent a TCR-specific accumulation in response to an antigenic stimuli that is present in the adipose tissue of HIV-infected persons but is not homologous or highly conserved; 1 example might be diverse proteins or lipids altered by local inflammation or oxidative damage. Notably, animal studies have also identified a predominance of specific TCR Va and Vb chain families in the adipose tissue of obese animals (although not using the sequencing approach we used). 24, 26, 37 Although these previous studies and our results do not resolve the etiology of the clonal CD8 + T-cell repertoire, the similar findings in animal models of obesity suggest that the stimuli originate in the adipose tissue and are not specific to HIV-infected persons.
The primary limitations of our study were the small sample size, quantity of adipose tissue T cells collected, and the technical challenge of eliminating peripheral blood FIGURE 1. Greater clonality of the CD8 + TCRb repertoire in adipose tissue compared with blood. Colored bars represent the relative proportion of all productive CD8 + TCRb sequences from each subject's paired adipose tissue and blood that comprised the 10 most prevalent clones (red bar), the 100 most prevalent clones (dark orange bar), etc. Proportional downsampling and bootstrapping were used to account for read-count distribution differences between tissue compartments. The 10 most prevalent TCRb clones comprised a larger percentage of total clones in adipose tissue compared with paired blood in all 5 subjects (25% vs. 16% of total repertoire, respectively; P = 0.04), and the Shannon Entropy index, a measure of overall repertoire diversity, was lower in adipose tissue compared with blood (4.39 vs. 4.46, respectively; P = 0.05).
contamination from the liposuction aspirate. Our group collected only 3-5 g of adipose tissue from each participant, and the yield of sorted CD4 + and CD8 + T cells was insufficient to perform TCRb sequencing or latent HIV quantification on all subjects. Liposuction requires the infiltration of lidocaine and saline (ie, tumescent fluid) before tissue aspiration, and the mechanical trauma leads to contamination of this fluid with blood. Although our adipose tissue aspirates were repeatedly rinsed before enzymatic and mechanical digestion, we observed lower absolute expression of CD69 on CD4 + and CD8 + memory T cells compared with previous reports from HIV-infected humans and SIV-infected macaques (although we did find 20-fold higher CD69 expression on our adipose CD4 + memory cells compared with blood). 35, 36, 59 In the absence of problems with antibody binding, which we do not suspect, this lower absolute CD69 expression on memory CD4 + T cells suggests a degree of contamination by peripheral T cells. Such contamination would have biased our comparisons of T-cell subset percentages in blood versus adipose tissue toward the null, and therefore, the true differences between compartments may actually be more pronounced than we report. Going forward, our group has developed a protocol for multiple adipose tissue saline baths immediately after aspiration, and we are investigating potential surface markers indicative of T cells present in adipose tissue (ie, a "tissue-resident" phenotype), which could be used as a cell-sorting criterion.
Our study only sequenced CD8 + cell TCRs, which was based on previous studies demonstrating restricted CD8 + cell TCR gene families in mouse models of obesity and insulin resistance, 24, 26, 37 and to allow for latent HIV quantification on the CD4 + cells. Larger volumes of tissue aspiration in future studies will permit sequencing of both the CD8 + and CD4 + TCR repertoires. To reduce potential confounding from different ART regimens, our study only enrolled subjects with long-term viral suppression on EFV/TDF/FTC, but consequently, we could not assess the effect of unsuppressed viremia or other ART medications on T-cell profiles. Finally, larger studies enrolling subjects with a wider range of insulin resistance will be needed to assess the relationship between adipose tissue T-cell populations and glucose tolerance and metabolic disease more broadly.
In summary, our study demonstrates that subcutaneous adipose tissue from patients with HIV is enriched for activated and late-differentiated CD8 + T cells and is characterized by a disproportionate expansion of specific CD8 + T-cell clones compared with blood. We also demonstrate the feasibility of using liposuction to collect and extract adipose tissue T cells, and the use of TCRb sequencing to characterize receptor repertoire and gene segment usage in this cell population. Based on our findings, further studies are needed to understand the etiology of the observed oligoclonal CD8 + T-cell repertoire and its relationship to adipocyte function and metabolic disease in HIV-infected persons.
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